Literature DB >> 15839900

Bacterial delivery of functional messenger RNA to mammalian cells.

Christoph Schoen1, Annette Kolb-Mäurer, Gernot Geginat, Daniela Löffler, Birgit Bergmann, Jochen Stritzker, Aladar A Szalay, Sabine Pilgrim, Werner Goebel.   

Abstract

The limited access to the nuclear compartment may constitute one of the major barriers after bacteria-mediated expression plasmid DNA delivery to eukaryotic cells. Alternatively, a self-destructing Listeria monocytogenes strain was used to release translation-competent mRNA directly into the cytosol of epithelial cells, macrophages and human dendritic cells. Enhanced green fluorescent protein (EGFP)-encoding mRNA, adapted for translation in mammalian cells by linking an IRES element to the 5'-end of the egfp coding sequence, was produced by T7 RNA polymerase in the carrier bacteria upon entry into the cytosol where the mRNA is efficiently released from the lysed bacteria and immediately translated in eukaryotic host cells. Besides the much earlier expression of EGFP being detectable already 4 h after infection, the number of EGFP expressing mammalian cells obtained with this novel RNA delivery technique is comparable to or - especially in phagocytic cells - even higher than that obtained with the expression plasmid DNA delivery strategy. Accordingly, bacteria-mediated delivery of ovalbumin-encoding mRNA to macrophages resulted in efficient antigen processing and presentation in vitro indicating that this approach may also be adapted for the in vivo delivery of antigen-encoding mRNA leading to a more efficient immune response when applied to vaccine development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15839900     DOI: 10.1111/j.1462-5822.2005.00507.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  14 in total

1.  Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.

Authors:  Daniela I M Loeffler; Christoph U Schoen; Werner Goebel; Sabine Pilgrim
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

Review 3.  Bacteria as vectors for gene therapy of cancer.

Authors:  Chwanrow K Baban; Michelle Cronin; Deirdre O'Hanlon; Gerald C O'Sullivan; Mark Tangney
Journal:  Bioeng Bugs       Date:  2010 Nov-Dec

4.  The use of Listeria monocytogenes as a DNA delivery vector for cancer gene therapy.

Authors:  Mark Tangney; Jan Peter van Pijkeren; Cormac G M Gahan
Journal:  Bioeng Bugs       Date:  2010-03-07

5.  AAV's anatomy: roadmap for optimizing vectors for translational success.

Authors:  Angela M Mitchell; Sarah C Nicolson; Jayme K Warischalk; R Jude Samulski
Journal:  Curr Gene Ther       Date:  2010-10       Impact factor: 4.391

6.  Coexpression of human perforin improves yeast-mediated delivery of DNA and mRNA to mammalian antigen-presenting cells.

Authors:  B Walch-Rückheim; R Kiefer; G Geginat; M J Schmitt; F Breinig
Journal:  Gene Ther       Date:  2015-08-20       Impact factor: 5.250

7.  KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity.

Authors:  Mojca Skoberne; Alice Yewdall; Keith S Bahjat; Emmanuelle Godefroy; Peter Lauer; Edward Lemmens; Weiqun Liu; Will Luckett; Meredith Leong; Thomas W Dubensky; Dirk G Brockstedt; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2008-11-06       Impact factor: 14.808

8.  Specific antibody-receptor interactions trigger InlAB-independent uptake of Listeria monocytogenes into tumor cell lines.

Authors:  Martin Heisig; Alexa Frentzen; Birgit Bergmann; Katharina Galmbacher; Ivaylo Gentschev; Christian Hotz; Christoph Schoen; Jochen Stritzker; Joachim Fensterle; Ulf R Rapp; Werner Goebel
Journal:  BMC Microbiol       Date:  2011-07-11       Impact factor: 3.605

Review 9.  Live bacterial vaccine vectors: an overview.

Authors:  Adilson José da Silva; Teresa Cristina Zangirolami; Maria Teresa Marques Novo-Mansur; Roberto de Campos Giordano; Elizabeth Angélica Leme Martins
Journal:  Braz J Microbiol       Date:  2015-03-04       Impact factor: 2.476

Review 10.  Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery.

Authors:  Ivan Y C Lin; Thi Thu Hao Van; Peter M Smooker
Journal:  Vaccines (Basel)       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.